Clinical Trials Browser

OTHER × Has results × belantamab mafodotin × Clear all

NCT04676360 2026-03-13

Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma

Phase 2 Terminated

10 enrolled 11 charts

Plasmablastic Lymphoma

NCT04896658 2025-04-03

Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Phase 1/2 Terminated

10 enrolled 14 charts

Multiple Myeloma

NCT05117008 2025-01-28

EMBRACE

Phase 2 Terminated

1 enrolled 5 charts

Multiple Myeloma